Literature DB >> 28688665

B cells in tertiary lymphoid structures are associated with favorable prognosis in gastric cancer.

Chie Sakimura1, Hiroaki Tanaka2, Takahiro Okuno3, Soichiro Hiramatsu1, Kazuya Muguruma1, Kosei Hirakawa1, Hideki Wanibuchi3, Masaichi Ohira1.   

Abstract

BACKGROUND: The role of tumor-infiltrating B cells in the tumor microenvironment is still unclear. Recent studies have reported that B cells and tertiary lymphoid structures (TLSs) that contain B cell follicles correlate with the favorable prognosis of cancer patients. The aim of this study was to investigate the association between tumor-infiltrating B cells and clinicopathological features in gastric cancer.
METHODS: Tumor blocks were obtained from 226 patients with stage Ib to stage IV gastric cancer. The density of CD20+ B cells within the tumor and in the invasive margin area was assessed using immunohistochemistry. We also evaluated CD3+ T cells, CD21+ follicular dendritic cells, Bcl6+ germinal center B cells, and PNAd+ high endothelial venules to show the presence of TLSs.
RESULTS: Tumor-infiltrating B cells were mostly organized as clusters that were surrounded by CD3+ T cells. The B cell area contained follicular dendritic cells and some clusters contained Bcl6+ B cells. High endothelial venules were present around follicles. We identified these follicles as TLSs. A high number of CD20+ B cells were associated with significantly better overall survival, and multivariate analysis also showed that CD20 high was one of the independent predictors of prognosis. In addition, there was a significant correlation between CD20+ B cell and CD8+ T cell infiltration.
CONCLUSIONS: B cells mostly infiltrated tumors as TLSs and were associated with better prognosis in patients with gastric cancer.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  B cell; Gastric cancer; Tertiary lymphoid structure

Mesh:

Substances:

Year:  2017        PMID: 28688665     DOI: 10.1016/j.jss.2017.03.033

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  28 in total

1.  Tertiary lymphoid structure patterns predicted anti-PD1 therapeutic responses in gastric cancer.

Authors:  Quan Jiang; Chenyu Tian; Hao Wu; Lingqiang Min; Hao Chen; Lingli Chen; Fenglin Liu; Yihong Sun
Journal:  Chin J Cancer Res       Date:  2022-08-30       Impact factor: 4.026

2.  Clinical relevance of tertiary lymphoid structures in esophageal squamous cell carcinoma.

Authors:  Sota Deguchi; Hiroaki Tanaka; Shugo Suzuki; Seji Natsuki; Takuya Mori; Yuichiro Miki; Mami Yoshii; Tatsuro Tamura; Takahiro Toyokawa; Shigeru Lee; Kazuya Muguruma; Hideki Wanibuchi; Masaichi Ohira
Journal:  BMC Cancer       Date:  2022-06-24       Impact factor: 4.638

3.  Tumor infiltrating CD19+ B lymphocytes predict prognostic and therapeutic benefits in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors.

Authors:  Zhiyuan Lin; Li Liu; Yu Xia; Xiang Chen; Ying Xiong; Yang Qu; Jiajun Wang; Qi Bai; Jianming Guo; Jiejie Xu
Journal:  Oncoimmunology       Date:  2018-08-06       Impact factor: 8.110

Review 4.  The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy.

Authors:  Daniela Bruni; Helen K Angell; Jérôme Galon
Journal:  Nat Rev Cancer       Date:  2020-08-04       Impact factor: 60.716

5.  Intratumoral injection of activated B lymphoblast in combination with PD-1 blockade induces systemic antitumor immunity with reduction of local and distal tumors.

Authors:  Mario M Soldevilla; Helena Villanueva; Naiara Martinez-Velez; Daniel Meraviglia-Crivelli; Marta M Alonso; Javier Cebollero; Ashwathi P Menon; Montserrat Puigdelloses; Fernando Pastor
Journal:  Oncoimmunology       Date:  2018-04-09       Impact factor: 8.110

6.  Diffuse Reduction of Spleen Density Is an Independent Predictor of Post-Operative Outcomes After Curative Gastrectomy in Gastric Cancer: A Multi-Center Study.

Authors:  Yun-Shi Huang; Xiao-Dong Chen; Ming-Ming Shi; Li-Bin Xu; Su-Jun Wang; Wei-Sheng Chen; Guan-Bao Zhu; Wei-Teng Zhang; Xian Shen
Journal:  Front Oncol       Date:  2020-06-30       Impact factor: 6.244

7.  Single-cell transcriptome and antigen-immunoglobin analysis reveals the diversity of B cells in non-small cell lung cancer.

Authors:  Jian Chen; Yun Tan; Fenghuan Sun; Likun Hou; Chi Zhang; Tao Ge; Huansha Yu; Chunxiao Wu; Yuming Zhu; Liang Duan; Liang Wu; Nan Song; Liping Zhang; Wei Zhang; Di Wang; Chang Chen; Chunyan Wu; Gening Jiang; Peng Zhang
Journal:  Genome Biol       Date:  2020-06-24       Impact factor: 13.583

Review 8.  Tertiary Lymphoid Organs in Cancer Immunology: Mechanisms and the New Strategy for Immunotherapy.

Authors:  Liangbin Lin; Xiang Hu; Huiyuan Zhang; Hongbo Hu
Journal:  Front Immunol       Date:  2019-06-20       Impact factor: 7.561

9.  KRAS RENAISSANCE(S) in Tumor Infiltrating B Cells in Pancreatic Cancer.

Authors:  Qingda Meng; Davide Valentini; Martin Rao; Markus Maeurer
Journal:  Front Oncol       Date:  2018-09-19       Impact factor: 6.244

10.  A minority-group of renal cell cancer patients with high infiltration of CD20+B-cells is associated with poor prognosis.

Authors:  Elin Sjöberg; Magnus Frödin; John Lövrot; Artur Mezheyeuski; Martin Johansson; Ulrika Harmenberg; Lars Egevad; Per Sandström; Arne Östman
Journal:  Br J Cancer       Date:  2018-10-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.